Madeline A. Whitney

Mar 22, 2024 | bjaopen.org | Jordan Edwards |Charles R. Drew |Madeline A. Whitney |Bradford Smith

AbstractThis retrospective study evaluated the efficacy and safety of intraoperative methadone compared with short-acting opioids. Patients undergoing cardiac surgery with cardiopulmonary bypass (n=11 967) from 2018 to 2023 from a single health system were categorised into groups based on intraoperative opioid administration: no methadone (Group O), methadone plus other opioids (Group M+O), and methadone only (Group M).